EIGER BIOPHARMACEUTICALS INC — Form D/A

EIGER BIOPHARMACEUTICALS INC of Santa Clara, CA, a company, filed a Form D amendment with the SEC on 2014-09-05. The offering totals $7.1M, of which $6.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (10)

NameRoleLocation
Keith VendolaExecutive OfficerSt. Louis, MO
Nina KjellsonDirectorSanta Clara, CA
Thomas DietzDirectorResearch Triangle Park, NC
Glen SatoExecutive OfficerSanta Clara, CA
David CoryDirectorSanta Clara, CA
David CoryExecutive OfficerSanta Clara, CA
Ed EnglemanDirectorSanta Clara, CA
Jeffrey GlennDirectorSanta Clara, CA
Paul TruexDirectorSanta Clara, CA
Wenjin YangExecutive OfficerRedwood City, CA

Other filings by this issuer (9)

FiledFormOfferingSold
2015-11-20D$6.0M$6.0M
2015-03-24D/A$14.6M$14.5M
2015-02-17D/A$9.0M$8.7M
2014-11-20D/A$7.3M$7.2M
2014-04-11D/A$5.9M$5.8M
2013-05-14D/A$5.4M$5.3M
2012-08-29D/A$5.0M$4.6M
2011-04-27D$5.0M$3.5M
2010-09-20D/A$8.3M$8.3M

More